Cme (CME) Cash from Investing Activities (2010 - 2026)

Cme (CME) has reported Cash from Investing Activities for 17 consecutive years, with -$29.4 million the latest figure, recorded in Q2 2026.

• Quarterly Cash from Investing Activities fell 63.33% year-over-year to -$29.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 1767.12% YoY) and the FY2025 annual result came in at $1.5 billion, up 1914.53% from the prior year.
• Cash from Investing Activities slipped to -$29.4 million in Q2 2026 per CME's latest filing, from -$23.0 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for CME reached as high as $1.6 billion in Q4 2025 and fell as low as -$417.6 million in Q2 2022.
• A 5-year average of $49.7 million and a median of -$21.6 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 1128.24% — and 2025, when it soared 6233.99%.
• Year by year, Cash from Investing Activities stood at -$25.7 million in 2022, then increased by 20.62% to -$20.4 million in 2023, then declined by 24.02% to -$25.3 million in 2024, then surged by 6233.99% to $1.6 billion in 2025, then plunged by 101.89% to -$29.4 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$29.4 million, -$23.0 million, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.